Vantage Financial Partners (Wisconsin)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$225K Buy
643
+4
+0.6% +$1.35K 0.05% 190
2025
Q3
$207K Buy
639
+3
+0.5% +$933 0.04% 201
2025
Q2
$247K Buy
636
+3
+0.5% +$1.21K 0.06% 177
2025
Q1
$275K Sell
633
-16
-2% -$6.42K 0.07% 149
2024
Q4
$239K Sell
649
-537
-45% -$225K 0.06% 153
2024
Q3
$617K Buy
1,186
+80
+7% +$42.7K 0.15% 93
2024
Q2
$600K Buy
1,106
+16
+1% +$8.46K 0.16% 72
2024
Q1
$565K Buy
+1,090
New +$542K 0.15% 75

Other funds holding ELV

Vantage Financial Partners (Wisconsin)'s ELV Position: Q4 2025 in Review

Vantage Financial Partners (Wisconsin) increased its Elevance Health (ELV) stake by 0.63% in Q4 2025, buying an estimated $1.35K and bringing the position to 643 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #190.

Vantage Financial Partners (Wisconsin) first reported a position in ELV in Q1 2024 and has held it in 8 quarters since. The position peaked at $617K in Q3 2024. 1,559 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Vantage Financial Partners (Wisconsin) held 643 shares of Elevance Health worth $225K as of Q4 2025.
  • Vantage Financial Partners (Wisconsin) bought 4 Elevance Health shares in Q4 2025, an estimated $1.35K.
  • Elevance Health made up 0.05% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #190 holding.
  • Vantage Financial Partners (Wisconsin) first reported a position in Elevance Health in Q1 2024 and has held it in 8 quarters since.
  • Vantage Financial Partners (Wisconsin)'s Elevance Health position peaked at $617K in Q3 2024.
  • 1,559 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.